<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Frontal fibrosing alopecia: Pathogenesis, clinical manifestations, and diagnosis</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Frontal fibrosing alopecia: Pathogenesis, clinical manifestations, and diagnosis</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Frontal fibrosing alopecia: Pathogenesis, clinical manifestations, and diagnosis</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Oma N Agbai, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Maria Hordinsky, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Abena O Ofori, MD</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Aug 15, 2022.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H3100501787"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Frontal fibrosing alopecia (FFA) is a lymphocytic cicatricial (scarring) alopecia that classically presents with the progressive development of a symmetric, band-like patch of alopecia involving the frontal hairline  (<a class="graphic graphic_picture graphicRef127007 graphicRef127013 graphicRef101628 graphicRef90010" href="/d/graphic/127007.html" rel="external">picture 1A-D</a>). FFA is postulated to be a subtype of lichen planopilaris based upon the presence of similar histopathologic findings. (See  <a class="medical medical_review" href="/d/html/15680.html" rel="external">"Lichen planopilaris"</a>.)</p><p>FFA most frequently occurs in postmenopausal women but occasionally occurs in other adults. Additional clinical features may include extension of alopecia to the posterior hairline, eyebrows, or other body areas. Patients may also exhibit facial papules, small, skin-colored papules on the cheeks, chin, or temples. A diagnosis of FFA is made based upon the presence of consistent clinical and histopathologic findings.</p><p>The pathogenesis, clinical manifestations, and diagnosis of FFA are reviewed here. Therapeutic management of FFA is discussed separately. Overviews of lichen planopilaris and the evaluation of patients with hair loss are also provided separately.</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/110156.html" rel="external">"Frontal fibrosing alopecia: Management"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/15680.html" rel="external">"Lichen planopilaris"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/15678.html" rel="external">"Evaluation and diagnosis of hair loss"</a>.)</p><p></p><p class="headingAnchor" id="H3681214609"><span class="h1">CLASSIFICATION</span><span class="headingEndMark"> — </span>Classification of the various types of cicatricial alopecia is frequently based upon a system proposed by the North American Hair Research Society in 2001 [<a href="#rid1">1</a>]. FFA is classified as a primary lymphocytic cicatricial alopecia, a term used to describe a group of inflammatory scalp disorders that demonstrate a lymphocyte-predominant inflammatory infiltrate, follicular destruction, and permanent hair loss. (See  <a class="medical medical_review" href="/d/html/15678.html" rel="external">"Evaluation and diagnosis of hair loss", section on 'Classification'</a>.)</p><p class="headingAnchor" id="H1549330158"><span class="h1">EPIDEMIOLOGY</span><span class="headingEndMark"> — </span>Epidemiologic data on FFA are limited. FFA was first reported in 1994, and subsequently, reports of this diagnosis have continued to increase [<a href="#rid2">2,3</a>]. In a multicenter, retrospective study that included patients evaluated in specialist hair clinics in Europe, America, Africa, and Australia, FFA accounted for 11 percent of 3133 diagnoses of alopecia and 40 percent of 840 diagnoses of cicatricial alopecia [<a href="#rid4">4</a>].</p><p>FFA appears to be an adult-onset disorder; the disorder has not been reported in children. FFA is most frequently diagnosed in postmenopausal women between 55 and 70 years of age but may also occur in other adults [<a href="#rid5">5-11</a>]. In one of the largest series, a Spanish, multicenter, retrospective study, 83 percent of 355 patients with FFA were postmenopausal women [<a href="#rid5">5</a>]. Premenopausal women and men accounted for 14 and 3 percent of the patients, respectively. However, a review of 20 patients with histopathologically confirmed FFA in a single center in South Africa found a contrasting distribution; the patients included 5 postmenopausal women, 14 premenopausal women, and 1 man [<a href="#rid8">8</a>].</p><p class="headingAnchor" id="H1718388258"><span class="h1">PATHOGENESIS</span><span class="headingEndMark"> — </span>The pathogenesis of FFA is not well understood. Similar to lichen planopilaris (LPP), pathology specimens from FFA on the scalp typically demonstrate a dense, lymphohistiocytic, inflammatory infiltrate that targets the infundibular and isthmus regions of the hair follicle  (<a class="graphic graphic_figure graphicRef53952" href="/d/graphic/53952.html" rel="external">figure 1</a>) [<a href="#rid12">12</a>]. The follicular bulge, the site of stem cells involved in regeneration of hair follicles during follicular cycling, is within this region  (<a class="graphic graphic_figure graphicRef53952" href="/d/graphic/53952.html" rel="external">figure 1</a>). Damage to the follicular bulge is considered to contribute to the development of permanent alopecia.</p><p>Immune dysregulation, pathologic fibrotic pathways, and, as with LPP, downregulation of peroxisome proliferator-activated receptor-gamma gene expression have been postulated to play a role [<a href="#rid13">13</a>]. The reason for the preferential damage of follicles along the hairline in FFA is unknown. (See  <a class="medical medical_review" href="/d/html/15680.html" rel="external">"Lichen planopilaris", section on 'Pathogenesis'</a>.)</p><p>The stimuli that contribute to the onset of FFA remain unclear. A variety of factors have been proposed as contributors; examples include genetic predisposition, hormonal influences, and environmental factors:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Genetics</strong> – Reports of familial occurrences of FFA suggest a genetic contribution [<a href="#rid14">14-18</a>]. An autosomal dominant pattern of inheritance has been suggested based upon an analysis of five individuals with FFA in one family [<a href="#rid14">14</a>]. In addition, a case-control study in which human leukocyte antigen (HLA) profiles of 13 patients with FFA in 6 families were compared with data from 636 healthy controls found linkage of the HLA class 1 haplotype F16A with <em>CYP21A2</em> gene p. V28L, a potential genetic marker for familial susceptibility to FFA [<a href="#rid19">19</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Hormones</strong> – Suspicion for a hormonal contribution to FFA comes from the strong predilection for postmenopausal females, studies that suggest associations between FFA and alterations in estrogen or androgen levels, and apparent benefit of antiandrogen therapy. Reduced estrogen levels were postulated to contribute based upon a Spanish, retrospective study of 355 patients with FFA that found early menopause (≤45 years) in 14 percent of the women with FFA, a rate higher than estimated to occur in the general population, and a history of hysterectomy in 13 percent of women with FFA [<a href="#rid5">5</a>]. Moreover, 32 percent of 53 patients with FFA in a separate retrospective study had low adrenal androgen levels [<a href="#rid20">20</a>]. Lastly, inhibitors of 5-alpha reductase, antiandrogenic drugs, are thought to be beneficial treatments for FFA. (See  <a class="medical medical_review" href="/d/html/110156.html" rel="external">"Frontal fibrosing alopecia: Management", section on '5-alpha reductase inhibitors'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Environment</strong> – The onset of FFA in adulthood and the lack of recognition of this disease until 1994 has contributed to speculation regarding an environmental trigger for FFA. Sunscreen use has been proposed as one potential contributor, though a causative role for sunscreen has not been confirmed.</p><p></p><p class="bulletIndent1">Data supporting a relationship between FFA and sunscreen use primarily comes from questionnaire-based, case-control studies and case reports [<a href="#rid21">21</a>]. One of the largest studies, a multicenter, case-control study of 664 women (335 with FFA and 329 controls) and 106 men (20 with FFA and 86 controls) in which subjects completed a questionnaire that assessed environmental, dietary, and other exposures, found associations between FFA and use of facial sunscreen (odds ratio [OR] 1.6, 95% CI 1.06-2.41 for females and OR 11.6, 95% CI 1.7-80.9 for males) [<a href="#rid22">22</a>].</p><p></p><p class="bulletIndent1">There are conflicting data from retrospective studies regarding whether smoking has a protective effect against FFA [<a href="#rid3">3,5,23</a>]. Additional study is necessary to clarify the relationships among FFA, sunscreen and facial skin care product use, and smoking status.</p><p></p><p class="headingAnchor" id="H4112994605"><span class="h1">CLINICAL MANIFESTATIONS</span><span class="headingEndMark"> — </span>The clinical manifestations of FFA include a distinct pattern of hair loss on the scalp. Associated features may include hair loss on the eyebrows and/or other body sites and facial papules.</p><p class="headingAnchor" id="H2362467645"><span class="h2">Scalp</span><span class="headingEndMark"> — </span>Recession of the frontal and temporal hairline in a band-like pattern is the characteristic finding  (<a class="graphic graphic_picture graphicRef127007 graphicRef127013 graphicRef101628 graphicRef90010" href="/d/graphic/127007.html" rel="external">picture 1A-D</a>). The affected scalp shows a loss of follicular ostia [<a href="#rid24">24</a>], a finding consistent with cicatricial alopecia, and may also exhibit perifollicular hyperkeratosis and erythema, findings supportive of active inflammation  (<a class="graphic graphic_picture graphicRef127836 graphicRef127837" href="/d/graphic/127836.html" rel="external">picture 2A-B</a>) [<a href="#rid25">25,26</a>].</p><p>The "lonely hair" sign is an additional common finding. The sign describes the presence of one or a few remaining terminal hairs within a band of alopecia  (<a class="graphic graphic_picture graphicRef127007 graphicRef127013" href="/d/graphic/127007.html" rel="external">picture 1A-B</a>) [<a href="#rid27">27,28</a>].</p><p>Scalp hair loss typically manifests as slow, progressive recession of the anterior hairline. In one retrospective study, the average rate of hair loss was 1.05 cm per year (range 0.2 to 2.1 cm per year) among the 74 of 79 untreated patients who worsened during follow-up [<a href="#rid5">5</a>]. Occasionally, patients present with rapid hairline recession [<a href="#rid29">29</a>]. (See  <a class="medical medical_review" href="/d/html/110156.html" rel="external">"Frontal fibrosing alopecia: Management", section on 'Prognosis'</a>.)</p><p>A subset of patients with frontal hair loss due to FFA also develop alopecia on the occipital scalp or patchy alopecia  (<a class="graphic graphic_picture graphicRef90011" href="/d/graphic/90011.html" rel="external">picture 3</a>). In particular, occipital involvement may not be uncommon. Estimates of occipital involvement range from 7 to 32 percent of patients [<a href="#rid3">3,5,30</a>].</p><p>Associated symptoms may include pruritus, trichodynia (tenderness or burning), or tingling sensations on the scalp. In some patients, an evaluation for scalp pruritus leads to the discovery of frontotemporal hairline recession [<a href="#rid31">31</a>].</p><p class="headingAnchor" id="H389775792"><span class="h2">Other body sites</span><span class="headingEndMark"> — </span>Manifestations of FFA can extend beyond the scalp, including hair loss involving eyebrows, eyelashes, or other body areas and facial lesions.</p><p class="headingAnchor" id="H2752384222"><span class="h3">Hair loss</span><span class="headingEndMark"> — </span>Cicatricial alopecia of the eyebrows is estimated to occur in 40 to 95 percent of FFA patients and ranges from partial to total loss of eyebrow hair  (<a class="graphic graphic_picture graphicRef127841" href="/d/graphic/127841.html" rel="external">picture 4</a>) [<a href="#rid32">32</a>]. Thinning of the lateral eyebrows is the common finding and may precede the onset of frontotemporal hairline recession [<a href="#rid5">5,15,33</a>]. Eyelash loss is less common [<a href="#rid3">3,5,6,11,33</a>].</p><p>Alopecia of other locations on the body, such as limbs, pubic area, and axillae, is estimated to occur in 6 to 53 percent of patients [<a href="#rid32">32</a>]. Findings of cicatricial alopecia in biopsies taken from the limbs of patients with FFA were documented in a case report [<a href="#rid34">34</a>].</p><p class="headingAnchor" id="H459074258"><span class="h3">Facial lesions</span><span class="headingEndMark"> — </span>Facial papules, presenting as multiple small, noninflammatory papules on the temples, cheeks, or chin, are a common associated finding in FFA. Facial papules may be a manifestation of involvement of vellus hair follicles or another process [<a href="#rid35">35,36</a>]. (See <a class="local">'Histopathology'</a> below.)</p><p>Perifollicular erythema, with or without follicular keratosis, diffuse facial erythema, pigmented macules on the face, depression of frontal veins, and periauricular wrinkles have also been reported [<a href="#rid36">36-38</a>].</p><p class="headingAnchor" id="H2077009869"><span class="h2">Frontal fibrosing alopecia/lichen planopilaris overlap</span><span class="headingEndMark"> — </span>The term "frontal fibrosing alopecia/lichen planopilaris (FFA/LPP) overlap" has been used to refer to FFA occurring in association with patchy cicatricial alopecia with histopathologic findings consistent with LPP. Clinical findings include a smooth band of cicatricial alopecia across the frontal hairline and patches of cicatricial alopecia involving other locations on the scalp.</p><p>The overlap presentation occurs in a minority of patients with FFA. In one retrospective study, only 3 of 355 patients (1 percent) with FFA had findings consistent with LPP in other areas of the scalp [<a href="#rid5">5</a>]. A smaller, retrospective study found FFA/LPP overlap in 10 of 62 patients (16 percent) [<a href="#rid5">5,10</a>].</p><p class="headingAnchor" id="H3231634912"><span class="h1">HISTOPATHOLOGY</span><span class="headingEndMark"> — </span>Similar to lichen planopilaris (LPP), the histopathologic findings of FFA include perifollicular fibrosis and a lymphocytic infiltrate surrounding the isthmus and infundibulum of the hair follicle [<a href="#rid7">7,39-41</a>]. Although some subtle findings have been postulated to be distinct features of FFA (eg, sparing of the interfollicular epidermis and eosinophilic necrosis of cells of the external root sheath), there are no definitive distinguishing features [<a href="#rid7">7</a>].</p><p>Histopathologic findings in FFA-associated facial papules may vary; findings similar to the histopathology of LPP have been reported [<a href="#rid35">35</a>]. In contrast, one study found prominent sebaceous lobules with dilated ducts and an abnormal, elastic framework as the prominent features [<a href="#rid42">42</a>]. These findings were postulated to result from a preceding, subtle, inflammatory process.</p><p class="headingAnchor" id="H1777445980"><span class="h1">DIAGNOSIS</span><span class="headingEndMark"> — </span>A diagnosis of FFA may be strongly suspected based upon the history and physical findings; however, a biopsy is necessary to confirm the diagnosis. </p><p>FFA should always be considered when patients present with progressive recession of the frontotemporal hairline in a band-like distribution and a loss of visible follicular ostia within the area of alopecia. Additional supportive features may include:</p><p class="bulletIndent1"><span class="glyph">●</span>Postmenopausal female patient</p><p class="bulletIndent1"><span class="glyph">●</span>"Lonely hair" sign  (<a class="graphic graphic_picture graphicRef127007" href="/d/graphic/127007.html" rel="external">picture 1A</a>) (see <a class="local">'Scalp'</a> above)</p><p class="bulletIndent1"><span class="glyph">●</span>Perifollicular erythema or scale</p><p class="bulletIndent1"><span class="glyph">●</span>Scalp itching, tingling, burning, or tenderness</p><p class="bulletIndent1"><span class="glyph">●</span>Partial or total loss of eyebrow hair</p><p class="bulletIndent1"><span class="glyph">●</span>Facial papules </p><p></p><p>The absence of one or more of these supportive features does not exclude a diagnosis of FFA.</p><p>Dermoscopy may be a useful adjunctive tool for identifying characteristic findings. (See <a class="local">'Dermoscopy'</a> below.)</p><p class="headingAnchor" id="H3594032832"><span class="h2">History and physical examination</span><span class="headingEndMark"> — </span>The patient history should include:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Assessment of the duration and course of hair loss and associated symptoms</strong> – Patients with FFA may complain of slow, progressive recession of their hairline. This may be associated with scalp tingling, burning, itching, or tenderness. (See <a class="local">'Scalp'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Assessment for hair loss in other areas</strong> – Patients should be asked about eyebrow thinning and hair loss in other areas of the scalp or body, as these findings may accompany scalp involvement in FFA. (See <a class="local">'Other body sites'</a> above.)</p><p></p><p>The physical examination should include:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Thorough examination of the scalp and scalp hair</strong> – The physical examination should include a thorough examination of the scalp and scalp hair, which can be aided by using the wooden end of a cotton-tipped applicator, one held in each hand, to part the hair. In particular, the frontotemporal hairline and posterior hairline should be examined thoroughly to detect loss of follicular ostia, the "lonely hair" sign, and perifollicular erythema or scale. (See <a class="local">'Scalp'</a> above and <a class="local">'Dermoscopy'</a> below and  <a class="medical medical_review" href="/d/html/15678.html" rel="external">"Evaluation and diagnosis of hair loss", section on 'Physical examination'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Examination of the face, eyebrows, and other hair-bearing areas</strong> – Cicatricial alopecia may be present in the eyebrows or other hair-bearing areas of patients with FFA. Facial papules are a common associated finding. (See <a class="local">'Other body sites'</a> above.)</p><p></p><p class="headingAnchor" id="H3025666671"><span class="h2">Dermoscopy</span><span class="headingEndMark"> — </span>Dermoscopic findings of FFA include a reduction of follicular ostia (consistent with cicatricial alopecia), perifollicular erythema, follicular plugging, and perifollicular hyperkeratosis (peripilar casts)  (<a class="graphic graphic_picture graphicRef114988" href="/d/graphic/114988.html" rel="external">picture 5</a>) [<a href="#rid5">5,43-46</a>]. Perifollicular erythema suggests active disease [<a href="#rid43">43,47</a>].</p><p class="headingAnchor" id="H2034687836"><span class="h2">Biopsy</span><span class="headingEndMark"> — </span>A 4 mm punch biopsy processed with transverse sectioning should be performed to assess for histopathologic features of FFA. Ideally, both a viable hair follicle producing a growing hair shaft and an area of scarring alopecia should be included in the specimen.</p><p>In our experience, a single biopsy processed with transverse sectioning is usually sufficient for the diagnosis of FFA. However, some dermatopathologists prefer the receipt of two punch biopsies (one sectioned transversely and the other sectioned vertically), as it allows for evaluation of the hair follicles in both horizontal and vertical sections. (See <a class="local">'Histopathology'</a> above and  <a class="medical medical_review" href="/d/html/5577.html" rel="external">"Skin biopsy techniques", section on 'Biopsy techniques'</a>.)</p><p class="headingAnchor" id="H639689974"><span class="h1">DIFFERENTIAL DIAGNOSIS</span><span class="headingEndMark"> — </span>Other forms of alopecia share some clinical or histopathologic features with FFA. The recognition of key clinical or histopathologic findings can be useful for distinguishing FFA from other conditions:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Traction alopecia</strong> – Traction alopecia is a form of temporary or permanent hair loss that results from extended periods of traction forces on the hair, which, for example, can occur with tight ponytails or braids. Alopecia commonly involves the frontotemporal scalp but may occur in other locations on the scalp.</p><p></p><p class="bulletIndent1">The "fringe" sign, the persistence of vellus hairs at the frontal hairline, is a common finding in frontotemporal traction alopecia  (<a class="graphic graphic_picture graphicRef127017" href="/d/graphic/127017.html" rel="external">picture 6</a>) [<a href="#rid48">48</a>]. The "lonely hair" sign is more consistent with FFA  (<a class="graphic graphic_picture graphicRef127007" href="/d/graphic/127007.html" rel="external">picture 1A</a>).</p><p></p><p class="bulletIndent1">Also, in contrast to the significant, perifollicular, lymphocytic infiltrate seen in skin biopsies of FFA, inflammation tends to be mild or absent in traction alopecia. Other histopathologic findings of traction alopecia include an increase in the proportion of catagen hairs and the presence of miniaturized hair follicles and pigmented hair casts. (See  <a class="medical medical_review" href="/d/html/99226.html" rel="external">"Traction alopecia"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Female and male pattern hair loss (androgenetic alopecia)</strong> – Female and male pattern hair loss, also known as androgenetic alopecia, are slowly progressive, nonscarring alopecias that may involve the frontotemporal and/or vertex scalp  (<a class="graphic graphic_picture graphicRef127018 graphicRef120282" href="/d/graphic/127018.html" rel="external">picture 7A-B</a>). Hair loss typically follows characteristic patterns.</p><p></p><p class="bulletIndent1">In female and male pattern hair loss, miniaturized hairs are easily visualized on dermoscopic or histopathologic examination. In contrast to FFA, loss of follicular ostia is absent. (See  <a class="medical medical_review" href="/d/html/15679.html" rel="external">"Female pattern hair loss (androgenetic alopecia in females): Pathogenesis, clinical features, and diagnosis"</a> and  <a class="medical medical_review" href="/d/html/83783.html" rel="external">"Male pattern hair loss (androgenetic alopecia in males): Pathogenesis, clinical features, and diagnosis"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Alopecia areata </strong>– Alopecia areata is a nonscarring alopecia that presents with one or more well-demarcated, nonscarring patches of alopecia. The ophiasis pattern of alopecia areata, which is characterized by a band-like area of alopecia across the occipital scalp, may resemble occipital involvement of FFA  (<a class="graphic graphic_picture graphicRef52784" href="/d/graphic/52784.html" rel="external">picture 8</a>).</p><p></p><p class="bulletIndent1">Unlike FFA, follicular ostia remain intact in alopecia areata. Dermoscopic findings of alopecia areata can include exclamation point hairs and yellow and black dots. A peribulbar lymphocytic infiltrate is seen on histopathologic examination. (See  <a class="medical medical_review" href="/d/html/3320.html" rel="external">"Alopecia areata: Clinical manifestations and diagnosis"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Lichen planopilaris</strong> – Classic lichen planopilaris (LPP) typically presents with patches of alopecia with loss of follicular ostia, often involving the vertex and/or parietal areas of the scalp. Perifollicular erythema and follicular hyperkeratosis are usually present at the periphery of balding areas.</p><p></p><p class="bulletIndent1">Classic LPP and FFA share similar histopathologic features. The frontal band-like pattern of hair loss distinguishes FFA. (See  <a class="medical medical_review" href="/d/html/15680.html" rel="external">"Lichen planopilaris"</a> and <a class="local">'Histopathology'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Trichotillomania</strong> – Trichotillomania is a disorder in which individuals compulsively pull hair from the scalp or other areas, resulting in varying and often unusual patterns of hair loss. Broken hairs of varying lengths are typically present  (<a class="graphic graphic_picture graphicRef127020 graphicRef96906" href="/d/graphic/127020.html" rel="external">picture 9A-B</a>).</p><p></p><p class="bulletIndent1">The history and physical examination are usually sufficient for diagnosis. If performed, a biopsy may demonstrate follicular damage and an increased number of catagen/telogen hairs. (See  <a class="medical medical_review" href="/d/html/13698.html" rel="external">"Skin picking (excoriation) disorder and related disorders", section on 'Trichotillomania'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Cutaneous sarcoidosis</strong> – Rarely, cutaneous sarcoidosis may present with clinical findings of anterior hairline recession  (<a class="graphic graphic_picture graphicRef57221" href="/d/graphic/57221.html" rel="external">picture 10</a>) [<a href="#rid49">49</a>]. Associated features may include alopecia in psoriasis-like plaques or atrophic, yellow plaques on the scalp. The detection of noncaseating granulomas on a skin biopsy supports the diagnosis. (See  <a class="medical medical_review" href="/d/html/13762.html" rel="external">"Cutaneous manifestations of sarcoidosis", section on 'Special sites'</a>.)</p><p></p><p class="headingAnchor" id="H1763175416"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Overview</strong> – Frontal fibrosing alopecia (FFA) is a lymphocytic cicatricial (scarring) alopecia that classically presents with progressive regression of the frontal hairline. FFA may represent a subtype of lichen planopilaris (LPP). (See <a class="local">'Introduction'</a> above and <a class="local">'Classification'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Epidemiology</strong> – FFA is an adult-onset disorder that was first reported in 1994. The condition has primarily been reported in postmenopausal women but also occurs in other populations. (See <a class="local">'Epidemiology'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Pathogenesis</strong> – The pathogenesis of FFA is not well understood. Permanent hair loss is thought to result from an inflammatory process that results in damage to the follicular bulge. Immune dysregulation, pathologic fibrotic pathways, and downregulation of peroxisome proliferated-activator receptor-gamma gene expression may play a role. Genetic, hormonal, and environmental factors are also postulated to play a role. (See <a class="local">'Pathogenesis'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Clinical manifestations</strong>:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Scalp</strong> – The classic clinical presentation of FFA consists of progressive recession of the frontal hairline in a band-line pattern  (<a class="graphic graphic_picture graphicRef127007 graphicRef127013 graphicRef101628 graphicRef90010" href="/d/graphic/127007.html" rel="external">picture 1A-D</a>). The area of alopecia exhibits a loss of follicular ostia, a finding consistent with cicatricial alopecia. Hair-bearing follicles near the areas of alopecia may demonstrate perifollicular erythema and scale  (<a class="graphic graphic_picture graphicRef127836 graphicRef127837" href="/d/graphic/127836.html" rel="external">picture 2A-B</a>). Scalp pruritus, tenderness, or burning is common. (See <a class="local">'Clinical manifestations'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Other body sites</strong> – Frontal hair loss in FFA may be accompanied by other findings. Cicatricial alopecia of the occipital scalp is involved in a subset of patients. Patients may also exhibit loss of eyebrow or body hair  (<a class="graphic graphic_picture graphicRef127841" href="/d/graphic/127841.html" rel="external">picture 4</a>). Small facial papules on the temples, cheeks, or chin are common. (See <a class="local">'Other body sites'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Diagnosis</strong> – The diagnosis of FFA is made based upon the detection of consistent clinical and pathologic findings. The pathologic findings of FFA are similar to findings in LPP. Typical findings are perifollicular fibrosis and a lymphocytic infiltrate surrounding the isthmus and infundibulum of the hair follicle. (See <a class="local">'Diagnosis'</a> above.)</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Olsen EA, Bergfeld WF, Cotsarelis G, et al. Summary of North American Hair Research Society (NAHRS)-sponsored Workshop on Cicatricial Alopecia, Duke University Medical Center, February 10 and 11, 2001. J Am Acad Dermatol 2003; 48:103.</a></li><li><a class="nounderline abstract_t">Kossard S. Postmenopausal frontal fibrosing alopecia. Scarring alopecia in a pattern distribution. Arch Dermatol 1994; 130:770.</a></li><li><a class="nounderline abstract_t">MacDonald A, Clark C, Holmes S. Frontal fibrosing alopecia: a review of 60 cases. J Am Acad Dermatol 2012; 67:955.</a></li><li><a class="nounderline abstract_t">Vañó-Galván S, Saceda-Corralo D, Blume-Peytavi U, et al. Frequency of the Types of Alopecia at Twenty-Two Specialist Hair Clinics: A Multicenter Study. Skin Appendage Disord 2019; 5:309.</a></li><li><a class="nounderline abstract_t">Vañó-Galván S, Molina-Ruiz AM, Serrano-Falcón C, et al. Frontal fibrosing alopecia: a multicenter review of 355 patients. J Am Acad Dermatol 2014; 70:670.</a></li><li><a class="nounderline abstract_t">Ladizinski B, Bazakas A, Selim MA, Olsen EA. Frontal fibrosing alopecia: a retrospective review of 19 patients seen at Duke University. J Am Acad Dermatol 2013; 68:749.</a></li><li><a class="nounderline abstract_t">Poblet E, Jiménez F, Pascual A, Piqué E. Frontal fibrosing alopecia versus lichen planopilaris: a clinicopathological study. Int J Dermatol 2006; 45:375.</a></li><li><a class="nounderline abstract_t">Dlova NC, Jordaan HF, Skenjane A, et al. Frontal fibrosing alopecia: a clinical review of 20 black patients from South Africa. Br J Dermatol 2013; 169:939.</a></li><li><a class="nounderline abstract_t">Rayinda T, McSweeney SM, Dand N, et al. Clinical characteristics of male frontal fibrosing alopecia: a single-centre case series from London, UK. Br J Dermatol 2022; 186:195.</a></li><li><a class="nounderline abstract_t">Banka N, Mubki T, Bunagan MJ, et al. Frontal fibrosing alopecia: a retrospective clinical review of 62 patients with treatment outcome and long-term follow-up. Int J Dermatol 2014; 53:1324.</a></li><li><a class="nounderline abstract_t">Samrao A, Chew AL, Price V. Frontal fibrosing alopecia: a clinical review of 36 patients. Br J Dermatol 2010; 163:1296.</a></li><li><a class="nounderline abstract_t">Ma SA, Imadojemu S, Beer K, Seykora JT. Inflammatory features of frontal fibrosing alopecia. J Cutan Pathol 2017; 44:672.</a></li><li><a class="nounderline abstract_t">Tavakolpour S, Mahmoudi H, Abedini R, et al. Frontal fibrosing alopecia: An update on the hypothesis of pathogenesis and treatment. Int J Womens Dermatol 2019; 5:116.</a></li><li><a class="nounderline abstract_t">Tziotzios C, Fenton DA, Stefanato CM, McGrath JA. Familial frontal fibrosing alopecia. J Am Acad Dermatol 2015; 73:e37.</a></li><li><a class="nounderline abstract_t">Navarro-Belmonte MR, Navarro-López V, Ramírez-Boscà A, et al. Case series of familial frontal fibrosing alopecia and a review of the literature. J Cosmet Dermatol 2015; 14:64.</a></li><li><a class="nounderline abstract_t">Porriño-Bustamante ML, López-Nevot MÁ, Aneiros-Fernández J, et al. Familial frontal fibrosing alopecia: A cross-sectional study of 20 cases from nine families. Australas J Dermatol 2019; 60:e113.</a></li><li><a class="nounderline abstract_t">Missio DM, Dias MFRG, Trüeb RM. Familial Cicatricial Alopecia: Report of Familial Frontal Fibrosing Alopecia and Fibrosing Alopecia in a Pattern Distribution. Int J Trichology 2017; 9:130.</a></li><li><a class="nounderline abstract_t">Cranwell WC, Sinclair R. Familial frontal fibrosing alopecia treated with dutasteride, minoxidil and artificial hair transplantation. Australas J Dermatol 2017; 58:e94.</a></li><li><a class="nounderline abstract_t">Porriño-Bustamante ML, López-Nevot MÁ, Aneiros-Fernández J, et al. Study of Human Leukocyte Antigen (HLA) in 13 cases of familial frontal fibrosing alopecia: CYP21A2 gene p.V281L mutation from congenital adrenal hyperplasia linked to HLA class I haplotype HLA-A*33:01; B*14:02; C*08:02 as a genetic marker. Australas J Dermatol 2019; 60:e195.</a></li><li><a class="nounderline abstract_t">Ranasinghe GC, Piliang MP, Bergfeld WF. Prevalence of hormonal and endocrine dysfunction in patients with lichen planopilaris (LPP): A retrospective data analysis of 168 patients. J Am Acad Dermatol 2017; 76:314.</a></li><li><a class="nounderline abstract_t">Robinson G, McMichael A, Wang SQ, Lim HW. Sunscreen and frontal fibrosing alopecia: A review. J Am Acad Dermatol 2020; 82:723.</a></li><li><a class="nounderline abstract_t">Moreno-Arrones OM, Saceda-Corralo D, Rodrigues-Barata AR, et al. Risk factors associated with frontal fibrosing alopecia: a multicentre case-control study. Clin Exp Dermatol 2019; 44:404.</a></li><li><a class="nounderline abstract_t">Fonda-Pascual P, Saceda-Corralo D, Moreno-Arrones OM, et al. Frontal fibrosing alopecia and environment: may tobacco be protective? J Eur Acad Dermatol Venereol 2017; 31:e98.</a></li><li><a class="nounderline abstract_t">Camacho Martínez F, García-Hernández MJ, Mazuecos Blanca J. Postmenopausal frontal fibrosing alopecia. Br J Dermatol 1999; 140:1181.</a></li><li><a class="nounderline abstract_t">Chan DV, Kartono F, Ziegler R, et al. Absence of HLA-DR1 positivity in 2 familial cases of frontal fibrosing alopecia. J Am Acad Dermatol 2014; 71:e208.</a></li><li><a class="nounderline abstract_t">Chew AL, Bashir SJ, Wain EM, et al. Expanding the spectrum of frontal fibrosing alopecia: a unifying concept. J Am Acad Dermatol 2010; 63:653.</a></li><li><a class="nounderline abstract_t">Camacho FM. Lonely hair sign: not specific for frontal fibrosing alopecia. Arch Dermatol 2012; 148:1208.</a></li><li><a class="nounderline abstract_t">Tosti A, Miteva M, Torres F. Lonely hair: a clue to the diagnosis of frontal fibrosing alopecia. Arch Dermatol 2011; 147:1240.</a></li><li><a class="nounderline abstract_t">Chen W, Kigitsidou E, Prucha H, et al. Male frontal fibrosing alopecia with generalised hair loss. Australas J Dermatol 2014; 55:e37.</a></li><li><a class="nounderline abstract_t">Kanti V, Constantinou A, Reygagne P, et al. Frontal fibrosing alopecia: demographic and clinical characteristics of 490 cases. J Eur Acad Dermatol Venereol 2019; 33:1976.</a></li><li><a class="nounderline abstract_t">Ormaechea-Pérez N, López-Pestaña A, Zubizarreta-Salvador J, et al. Frontal Fibrosing Alopecia in Men: Presentations in 12 Cases and a Review of the Literature. Actas Dermosifiliogr 2016; 107:836.</a></li><li><a class="nounderline abstract_t">To D, Beecker J. Frontal Fibrosing Alopecia: Update and Review of Challenges and Successes. J Cutan Med Surg 2018; 22:182.</a></li><li><a class="nounderline abstract_t">Rallis E, Gregoriou S, Christofidou E, Rigopoulos D. Frontal fibrosing alopecia: to treat or not to treat? J Cutan Med Surg 2010; 14:161.</a></li><li><a class="nounderline abstract_t">Miteva M, Camacho I, Romanelli P, Tosti A. Acute hair loss on the limbs in frontal fibrosing alopecia: a clinicopathological study of two cases. Br J Dermatol 2010; 163:426.</a></li><li><a class="nounderline abstract_t">Donati A, Molina L, Doche I, et al. Facial papules in frontal fibrosing alopecia: evidence of vellus follicle involvement. Arch Dermatol 2011; 147:1424.</a></li><li><a class="nounderline abstract_t">López-Pestaña A, Tuneu A, Lobo C, et al. Facial lesions in frontal fibrosing alopecia (FFA): Clinicopathological features in a series of 12 cases. J Am Acad Dermatol 2015; 73:987.e1.</a></li><li><a class="nounderline abstract_t">Nanda S, De Bedout V, Hirt PA, et al. Increased Preauricular Wrinkles in Frontal Fibrosing Alopecia Compared to Age-Matched Controls: A Prospective Study of 64 Patients. Skin Appendage Disord 2020; 6:11.</a></li><li><a class="nounderline abstract_t">Vañó-Galván S, Rodrigues-Barata AR, Urech M, et al. Depression of the frontal veins: A new clinical sign of frontal fibrosing alopecia. J Am Acad Dermatol 2015; 72:1087.</a></li><li><a class="nounderline abstract_t">Tosti A, Piraccini BM, Iorizzo M, Misciali C. Frontal fibrosing alopecia in postmenopausal women. J Am Acad Dermatol 2005; 52:55.</a></li><li><a class="nounderline abstract_t">Donovan JC, Samrao A, Ruben BS, Price VH. Eyebrow regrowth in patients with frontal fibrosing alopecia treated with intralesional triamcinolone acetonide. Br J Dermatol 2010; 163:1142.</a></li><li><a class="nounderline abstract_t">Kossard S, Lee MS, Wilkinson B. Postmenopausal frontal fibrosing alopecia: a frontal variant of lichen planopilaris. J Am Acad Dermatol 1997; 36:59.</a></li><li><a class="nounderline abstract_t">Pirmez R, Barreto T, Duque-Estrada B, et al. Facial Papules in Frontal Fibrosing Alopecia: Beyond Vellus Hair Follicle Involvement. Skin Appendage Disord 2018; 4:145.</a></li><li><a class="nounderline abstract_t">Toledo-Pastrana T, Hernández MJ, Camacho Martínez FM. Perifollicular erythema as a trichoscopy sign of progression in frontal fibrosing alopecia. Int J Trichology 2013; 5:151.</a></li><li><a class="nounderline abstract_t">Rubegni P, Mandato F, Fimiani M. Frontal Fibrosing Alopecia: Role of Dermoscopy in Differential Diagnosis. Case Rep Dermatol 2010; 2:40.</a></li><li><a class="nounderline abstract_t">Mireles-Rocha H, Sánchez-Dueñas LE, Hernández-Torres M. [Frontal fibrosing alopecia: dermoscopic features]. Actas Dermosifiliogr 2012; 103:167.</a></li><li><a class="nounderline abstract_t">Inui S, Nakajima T, Shono F, Itami S. Dermoscopic findings in frontal fibrosing alopecia: report of four cases. Int J Dermatol 2008; 47:796.</a></li><li><a class="nounderline abstract_t">Fernández-Crehuet P, Rodrigues-Barata AR, Vañó-Galván S, et al. Trichoscopic features of frontal fibrosing alopecia: results in 249 patients. J Am Acad Dermatol 2015; 72:357.</a></li><li><a class="nounderline abstract_t">Samrao A, Price VH, Zedek D, Mirmirani P. The "Fringe Sign" - A useful clinical finding in traction alopecia of the marginal hair line. Dermatol Online J 2011; 17:1.</a></li><li><a class="nounderline abstract_t">Ranasinghe GC, Hogan S, Ibrahim O, Piliang MP. Sarcoidosis Presenting as Frontal Fibrosing Alopecia: A Master Mimicker or a Coincidental Finding? Am J Dermatopathol 2018; 40:73.</a></li></ol></div><div id="topicVersionRevision">Topic 128536 Version 5.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12522378" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Summary of North American Hair Research Society (NAHRS)-sponsored Workshop on Cicatricial Alopecia, Duke University Medical Center, February 10 and 11, 2001.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8002649" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Postmenopausal frontal fibrosing alopecia. Scarring alopecia in a pattern distribution.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22503342" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Frontal fibrosing alopecia: a review of 60 cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31559256" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Frequency of the Types of Alopecia at Twenty-Two Specialist Hair Clinics: A Multicenter Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24508293" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Frontal fibrosing alopecia: a multicenter review of 355 patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23375454" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Frontal fibrosing alopecia: a retrospective review of 19 patients seen at Duke University.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16650161" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Frontal fibrosing alopecia versus lichen planopilaris: a clinicopathological study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23647261" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Frontal fibrosing alopecia: a clinical review of 20 black patients from South Africa.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34480347" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Clinical characteristics of male frontal fibrosing alopecia: a single-centre case series from London, UK.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24738979" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Frontal fibrosing alopecia: a retrospective clinical review of 62 patients with treatment outcome and long-term follow-up.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20698851" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Frontal fibrosing alopecia: a clinical review of 36 patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28429464" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Inflammatory features of frontal fibrosing alopecia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30997385" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Frontal fibrosing alopecia: An update on the hypothesis of pathogenesis and treatment.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26089074" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Familial frontal fibrosing alopecia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25614294" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Case series of familial frontal fibrosing alopecia and a review of the literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30430555" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Familial frontal fibrosing alopecia: A cross-sectional study of 20 cases from nine families.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28932068" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Familial Cicatricial Alopecia: Report of Familial Frontal Fibrosing Alopecia and Fibrosing Alopecia in a Pattern Distribution.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27273740" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Familial frontal fibrosing alopecia treated with dutasteride, minoxidil and artificial hair transplantation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30656636" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Study of Human Leukocyte Antigen (HLA) in 13 cases of familial frontal fibrosing alopecia: CYP21A2 gene p.V281L mutation from congenital adrenal hyperplasia linked to HLA class I haplotype HLA-A*33:01; B*14:02; C*08:02 as a genetic marker.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28088992" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Prevalence of hormonal and endocrine dysfunction in patients with lichen planopilaris (LPP): A retrospective data analysis of 168 patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31654665" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Sunscreen and frontal fibrosing alopecia: A review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30259544" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Risk factors associated with frontal fibrosing alopecia: a multicentre case-control study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27428753" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Frontal fibrosing alopecia and environment: may tobacco be protective?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10354100" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Postmenopausal frontal fibrosing alopecia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25437995" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Absence of HLA-DR1 positivity in 2 familial cases of frontal fibrosing alopecia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20846567" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Expanding the spectrum of frontal fibrosing alopecia: a unifying concept.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23069969" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Lonely hair sign: not specific for frontal fibrosing alopecia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22006155" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Lonely hair: a clue to the diagnosis of frontal fibrosing alopecia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24720432" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Male frontal fibrosing alopecia with generalised hair loss.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31179579" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Frontal fibrosing alopecia: demographic and clinical characteristics of 490 cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27499250" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Frontal Fibrosing Alopecia in Men: Presentations in 12 Cases and a Review of the Literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29056083" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Frontal Fibrosing Alopecia: Update and Review of Challenges and Successes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20642984" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Frontal fibrosing alopecia: to treat or not to treat?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20394630" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Acute hair loss on the limbs in frontal fibrosing alopecia: a clinicopathological study of two cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22184764" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Facial papules in frontal fibrosing alopecia: evidence of vellus follicle involvement.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26432059" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Facial lesions in frontal fibrosing alopecia (FFA): Clinicopathological features in a series of 12 cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32021855" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Increased Preauricular Wrinkles in Frontal Fibrosing Alopecia Compared to Age-Matched Controls: A Prospective Study of 64 Patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25981009" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Depression of the frontal veins: A new clinical sign of frontal fibrosing alopecia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15627081" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Frontal fibrosing alopecia in postmenopausal women.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20716217" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Eyebrow regrowth in patients with frontal fibrosing alopecia treated with intralesional triamcinolone acetonide.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8996262" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Postmenopausal frontal fibrosing alopecia: a frontal variant of lichen planopilaris.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30197890" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Facial Papules in Frontal Fibrosing Alopecia: Beyond Vellus Hair Follicle Involvement.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24574696" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Perifollicular erythema as a trichoscopy sign of progression in frontal fibrosing alopecia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21173926" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Frontal Fibrosing Alopecia: Role of Dermoscopy in Differential Diagnosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21925632" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : [Frontal fibrosing alopecia: dermoscopic features].</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18717858" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Dermoscopic findings in frontal fibrosing alopecia: report of four cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25592346" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Trichoscopic features of frontal fibrosing alopecia: results in 249 patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22136857" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : The "Fringe Sign" - A useful clinical finding in traction alopecia of the marginal hair line.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29293480" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Sarcoidosis Presenting as Frontal Fibrosing Alopecia: A Master Mimicker or a Coincidental Finding?</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
